Institutional investors hold a majority ownership of CELG through the 83.12% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended June 2014, these large investors purchased a net $9.2 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
STANDARD LIFE INVESTMENTS LTD. Bought 147.1 Thousand shares of Celgene Corp
DEGROOF FUND MANAGEMENT COMPANY ... Bought 34.7 Thousand shares of Celgene Corp
STANDARD LIFE INVESTMENTS, INC. ... Bought 33.9 Thousand shares of Celgene Corp